Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Jui Yu Chen"'
Autor:
Li-Hsin Pan, Jen-Fan Hang, Jui-Yu Chen, Po-Sheng Lee, Yun-Kai Yeh, Tai-Jung Huang, Chii-Min Hwu, Chin-Sung Kuo
Publikováno v:
Case Reports in Endocrinology, Vol 2024 (2024)
Background. Cribriform morular thyroid carcinoma has been recently renamed in the 2022 WHO classification as a thyroid tumor of uncertain histogenesis. The epidemiologic, pathological, and pathophysiological characteristics distinguish it from papill
Externí odkaz:
https://doaj.org/article/46a422706251409780371dab40db1ec6
Autor:
Jui-Yu Chen1 juiychen@fcu.edu.tw
Publikováno v:
Corporate Management Review. 12/31/2023, Vol. 43 Issue 2, p1-35. 35p.
Publikováno v:
Medicine; 8/23/2024, Vol. 103 Issue 34, p1-6, 6p
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 391 (2022)
Spectralis optical coherence tomography (OCT) provided more detailed parameters in the peripapillary and macular areas among the OCT machines, but it is not easy to understand the enormous information (114 features) generated from Spectralis OCT in g
Externí odkaz:
https://doaj.org/article/933620e597464fefb4eeac53dbc6ea15
Publikováno v:
Taiwanese Journal of Obstetrics & Gynecology, Vol 57, Iss 5, Pp 683-687 (2018)
Objective: To determine the normal values of flow mediated dilatation (FMD) in Taiwanese women with normal singleton pregnancies for the early detection of preeclampsia. Materials and methods: Data of women with normal singleton pregnancies seen at t
Externí odkaz:
https://doaj.org/article/f0fe59f19830455dbe19b5b5977be20f
Autor:
Chih-Sheng Chiang, Bo-Jie Huang, Jui-Yu Chen, Wee Wei Chieng, Seh Hong Lim, Wei Lee, Weoi-Cherng Shyu, Long-Bin Jeng
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 1986 (2021)
The anticancer properties of fucoidan have been widely studied in cancer research. However, the lack of safety information on the parenteral administration of fucoidan and its rapid clearance from the system have limited its application. Herein, we a
Externí odkaz:
https://doaj.org/article/bd12f7451f4c4d1ebf8b73c9564faff7
Publikováno v:
2022 IEEE 5th International Conference on Knowledge Innovation and Invention (ICKII ).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceb61530236fd5d8f1346daeabc3229c
https://doi.org/10.1109/ickii55100.2022.9983586
https://doi.org/10.1109/ickii55100.2022.9983586
Publikováno v:
Reports, Vol 2, Iss 3, p 22 (2019)
Anaplastic thyroid carcinoma (ATC) is a fatal disease with a poor prognosis. Lenvatinib is an oral multi-targeted tyrosine kinase inhibitor (TKI) which is approved in Japan for the treatment of ATC. Data of treatment response and adverse effects of l
Externí odkaz:
https://doaj.org/article/a3c2f375bb0e45aead6de4ff5146a5bb
Publikováno v:
Journal of the Chinese Medical Association : JCMA. 85(3)
Calcimimetics is a new drug for lowering serum parathyroid hormone (PTH), calcium and phosphate in patients with hyperparathyroidism (HPT) on long-term dialysis. It became available on market in 2006. The impact of calcimimetics on the treatment by p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c83773f97bee02663236ffa0b5dc4a
https://pubmed.ncbi.nlm.nih.gov/35259131
https://pubmed.ncbi.nlm.nih.gov/35259131
Publikováno v:
Endocrine Pathology. 31:348-358
NTRK1/3 rearrangements have been reported in 2.3-3.4% of papillary thyroid carcinoma (PTC) and are regarded as potential therapeutic targets. Recently, the application of immunohistochemistry (IHC) to detect NTRK rearrangements has been widely discus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca2798281e59eb5f423991e67964080
https://doi.org/10.1007/s12022-020-09648-9
https://doi.org/10.1007/s12022-020-09648-9